256 results
Responsible body
CHMP Remove CHMP filter
-
List item
Press release: EMA fast-tracks new oral treatment for non-small cell lung cancer
CHMP, Last updated: 18/12/2015epidermal growth factor receptor (EGFR). Lung cancer is among the … the tissues of the lung. EGFR is a protein involved in … developed a mutation in the EGFR gene. Mutations of the … -
List item
News: New add-on treatment for rare autoimmune inflammatory disorder
CHMP, Last updated: 17/09/2021granulomatosis with polyangiitis (EGPA), a rare disorder that causes … diagnosed each year with EGPA (also known as Churg-Strauss … Currently, most patients with EGPA are treated with anti-inflammatory … -
List item
News: EU recommendations for 2020/2021 seasonal flu vaccine composition
CHMP, Last updated: 01/04/2020autumn 2020. Manufacturers of egg-based or live attenuated trivalent … -
List item
News: EU recommendations for 2023-2024 seasonal flu vaccine composition
CHMP, Last updated: 04/04/2023autumn 2023. Manufacturers of egg-based or live attenuated quadrivalent … vaccines should contain: Egg-based or Live attenuated Vaccines … following strains be accepted: Egg-derived vaccines As an A/Victoria/4897/2022 … -
List item
News: EU recommendations for 2022-2023 seasonal flu vaccine composition
CHMP, Last updated: 29/03/2022autumn 2022. Manufacturers of egg-based or live attenuated quadrivalent … vaccines should contain: Egg-based or Live attenuated Vaccines … following strains be accepted: Egg-derived vaccines As an A/Victoria/2570/2019 … -
List item
Press release: Merck KGaA withdraws its application for an extension of the indication for Erbitux (cetuximab)
CHMP, Last updated: 19/09/2012epidermal-growth-factor receptor (EGFR)-expressing, KRAS-wild-type metastatic … epidermal growth factor receptor (EGFR)-expressing, KRAS wild-type metastatic … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 November 2014
CHMP, Last updated: 21/11/2014Egranli … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,27-30 May 2008
CHMP, Last updated: 02/06/2008epidermal growth factor receptor (EGFR)-expressing, KRAS wild-type metastatic … colorectal cancer expressing EGFR after failure of irinotecan … epidermal growth factor receptor (EGFR)-expressing, KRAS wild-type metastatic … -
List item
Press release: Further measures to minimise risk of osteonecrosis of the jaw with bisphosphonate medicine
CHMP, Last updated: 27/03/2015to undergo dental surgery (e.g. tooth extractions), inform … to undergo dental surgery (e.g. tooth extractions), inform … Cancer, co-morbid conditions (e.g. anaemia, coagulopathies … -
List item
Press release: CHMP recommends authorisation of new treatment for phenylketonuria, a rare inherited metabolic disease
CHMP, Last updated: 01/03/2019foods (such as meat, fish, eggs, nuts, legumes and corn) to … -
List item
Press release: Proposals to revise guidance on first-in-human clinical trials
CHMP, Last updated: 21/07/2016clinical trial protocol (e.g. to assess single and multiple … clinical trial protocol (e.g. to assess single and multiple … treated on multiple occasions (e.g. once a day for a week … -
List item
Press release: Re-analysis of data on use of breast cancer medicine Tyverb following treatment with trastuzumab
CHMP, Last updated: 30/04/2019efficacy results of study EGF114299, which evaluated the efficacy … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 September 2014
CHMP, Last updated: 26/09/2014Egranli … -
List item
Press release: Better training tools recommended to support patients using adrenaline auto-injectors
CHMP, Last updated: 26/06/2015the auto-injector works (e.g. if it is spring loaded or … the auto-injector works (e.g. if it is spring loaded or … the auto-injector works (e.g. if it is spring loaded or … -
List item
Press release: Benefits of combined hormonal contraceptives (CHCs) continue to outweigh risks – CHMP endorses PRAC recommendation
CHMP, Last updated: 22/11/2013at a relatively young age (e.g. below 50), having migraine … immobilised for a long time (e.g. because of an illness or … at a relatively young age (e.g. below 50), having migraine … -
List item
Press release: EMA recommends that Symbioflor 2 can continue to be used for irritable bowel syndrome
CHMP, Last updated: 23/06/2017different features of IBS (e.g. those with diarrhoea or … different features of IBS (e.g. those with diarrhoea or … -
List item
Press release: EMA recommends measures to ensure safe use of Keppra oral solution
CHMP, Last updated: 14/10/2016with a wrong dosing syringe (e.g. a 10 ml syringe was used … with a wrong dosing syringe (e.g. a 10 ml syringe was used … -
List item
Press release: European Medicines Agency recommends first medical treatment for patients with short bowel syndrome
CHMP, Last updated: 22/06/2012with serious complications, e.g. infection of the catheter … with serious complications, e.g. infection of the catheter … -
List item
Press release: EMA confirms recommendations to minimise risk of brain infection PML with Tysabri
CHMP, Last updated: 26/02/2016more frequent MRI scans (e.g. every 3 to 6 months) performed … more frequent MRI scans (e.g. every 3 to 6 months) performed … PML, more frequent MRIs (e.g. every 3-6 months) using … -
List item
News: EMA starts review of dexamethasone for treating adults with COVID-19 requiring respiratory support
CHMP, Last updated: 02/09/2020ventilation, those given oxygen (e.g. through a mask) or those … -
List item
Press release: EMA restricts use of prostate cancer medicine Xofigo
CHMP, Last updated: 27/07/2018of patients' bone status (e.g. by scintigraphy, bone mineral … measurement) and risk of fractures (e.g. osteoporosis, fewer than … -
List item
Press release: European Medicines Agency recommends approval of first-in-class treatment for metastatic or unresectable melanoma
CHMP, Last updated: 16/12/2011managed in clinical practice, e.g. by routine monitoring during … managed in clinical practice, e.g. by routine monitoring during … -
List item
Press release: Review of the manufacture of Baxter's peritoneal dialysis solutions initiated over potential presence of endotoxins in some batches
CHMP, Last updated: 21/01/2011development of aseptic peritonitis (e.g. cloudy effluent seen in … development of aseptic peritonitis (e.g. cloudy effluent seen in … -
List item
Press release: European Medicines Agency recommends action plan to deal with possible presence of endotoxins in Baxter peritoneal dialysis solutions
CHMP, Last updated: 17/12/2010developing aseptic peritonitis (e.g. cloudy effluent seen in … developing aseptic peritonitis (e.g. cloudy effluent seen in … -
List item
News: Public statement on possible interaction between clopidogrel and proton pump inhibitors
CHMP, Last updated: 29/05/2009involving harmful clotting (e.g. strokes). However, as different … involving harmful clotting (e.g. strokes). However, as different …